하이드록시아파타이트 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별, 용도별, 지역별 세분화 및 경쟁 구도(2020-2030년)

The Global Hydroxyapatite Market, valued at USD 2.61 Billion in 2024, is projected to experience a CAGR of 6.13% to reach USD 3.73 Billion by 2030. Hydroxyapatite is a naturally occurring mineral form of calcium apatite, serving as the primary inorganic component of human bone and teeth, thereby providing structural rigidity and strength. The global market for this bioceramic is supported by several fundamental drivers, including the escalating incidence of orthopedic and dental conditions, particularly within an aging global populace, and the increasing demand for biocompatible materials in advanced medical and dental applications. Furthermore, rising global healthcare expenditures contribute to expanded access to hydroxyapatite-based products.

Key Market Drivers

The rising prevalence of bone and dental disorders represents a significant catalyst for the global hydroxyapatite market, directly stimulating demand for biocompatible materials in restorative and reconstructive procedures. As populations age and lifestyle factors contribute to increased incidences of skeletal and oral health issues, the need for effective treatment solutions intensifies. Hydroxyapatite, as the primary mineral component of natural bone and teeth, is critical in applications such as bone grafts, dental implants, and enamel repair, offering excellent osseointegration and biocompatibility. The urgency for these interventions is underscored by the substantial burden of these conditions. According to the International Osteoporosis Foundation, in October 2024, "On World Osteoporosis Day, experts warn of growing burden of fragility fractures" reported that up to 37 million fragility fractures occur annually worldwide in individuals aged over 55. This high incidence drives the continuous demand for advanced biomaterials capable of facilitating bone regeneration and structural support.

Key Market Challenges

The high production cost associated with manufacturing high-purity, medical-grade hydroxyapatite, particularly its nano-sized variants, presents a significant impediment to market expansion. This directly hampers the growth of the Global Hydroxyapatite Market by affecting its overall affordability and accessibility across diverse market segments. Achieving the stringent purity levels and specific structural characteristics required for medical and dental applications, especially for nano-scale hydroxyapatite, necessitates complex manufacturing processes, specialized equipment, and rigorous quality control. These factors collectively drive up unit production costs, making final products less competitive compared to conventional or alternative materials.

Key Market Trends

The global hydroxyapatite market is significantly influenced by the continuous advancements in nano-hydroxyapatite technology. These innovations focus on enhancing the material's inherent properties, leading to superior performance in various applications. Nano-hydroxyapatite, with its increased surface area and reactivity due to its nanoscale structure, facilitates improved integration with biological systems and other matrices. For instance, according to an NIH 2023 report, experimental work demonstrated up to a 30% increase in bone formation on implant surfaces when utilizing nano-hydroxyapatite, indicating substantial progress in osseointegration capabilities. This material refinement allows for more effective drug delivery systems and advanced bone tissue engineering solutions, expanding its utility beyond traditional forms into more sophisticated medical and dental devices.

Key Market Players

• Sofsera Corporation
• Taihei Chemical Industrial Co. Ltd
• Cam Bioceramics BV
• APS Materials Inc.
• Granulab (M) Sdn Bhd
• Berkeley Advanced Biomaterials Inc.
• Zimmer Biomet Holdings Inc
• CG Bio Inc.
• Bio-Rad Laboratories Inc.
• Fluidinova S.A.

Report Scope:

In this report, the Global Hydroxyapatite Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hydroxyapatite Market, By Type:

• Nano-Sized
• Micro-Sized
• Greater than Micrometer

Hydroxyapatite Market, By Application:

• Orthopedic
• Plastic Surgery
• Dental Care
• Others

Hydroxyapatite Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hydroxyapatite Market.

Available Customizations:

Global Hydroxyapatite Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hydroxyapatite Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Nano-Sized, Micro-Sized, Greater than Micrometer)
  • 5.2.2. By Application (Orthopedic, Plastic Surgery, Dental Care, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Hydroxyapatite Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hydroxyapatite Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Hydroxyapatite Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Hydroxyapatite Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Hydroxyapatite Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hydroxyapatite Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. France Hydroxyapatite Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Hydroxyapatite Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Hydroxyapatite Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Hydroxyapatite Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Hydroxyapatite Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hydroxyapatite Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Hydroxyapatite Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Hydroxyapatite Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Hydroxyapatite Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Hydroxyapatite Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. Middle East & Africa Hydroxyapatite Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hydroxyapatite Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Hydroxyapatite Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Hydroxyapatite Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. South America Hydroxyapatite Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hydroxyapatite Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Hydroxyapatite Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Hydroxyapatite Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hydroxyapatite Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sofsera Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Taihei Chemical Industrial Co. Ltd
• 15.3. Cam Bioceramics BV
• 15.4. APS Materials Inc.
• 15.5. Granulab (M) Sdn Bhd
• 15.6. Berkeley Advanced Biomaterials Inc.
• 15.7. Zimmer Biomet Holdings Inc
• 15.8. CG Bio Inc.
• 15.9. Bio-Rad Laboratories Inc.
• 15.10. Fluidinova S.A.

16. Strategic Recommendations

17. About Us & Disclaimer